History Channel Documentary Featuring MassRoots Set to Air on Monday, January 11, 2016
Jan 06, 2016 13:00 pm UTC| Business
DENVER, Jan. 06, 2016 (GLOBE NEWSWIRE) -- MassRoots, Inc. (OTCQB:MSRT), one of the largest and fastest growing technology platforms for the cannabis industry, is pleased to announce it will be featured in, “The Marijuana...
Jan 06, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Dimension Therapeutics, Inc. (NASDAQ:DMTX), a leading gene therapy company advancing novel, liver-directed treatments for diverse rare diseases, today announced that...
Truxton Trust Company Adds Drew Mallory in Wealth Management Services
Jan 06, 2016 13:00 pm UTC| Business
NASHVILLE, Tenn., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Truxton Trust (OTCPK:TRUX) today announced that Drew Mallory has joined the firm as Managing Director. Drew joins Truxton after leading a $12 billion portfolio...
Kite Pharma to Present at the 34th Annual J.P. Morgan Healthcare Conference
Jan 06, 2016 13:00 pm UTC| Business
SANTA MONICA, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (NASDAQ:KITE) today announced that Arie Belldegrun, M.D., FACS, Chairman, President and Chief Executive Officer, will present at the 34th Annual...
Papa Murphy's Holdings, Inc. to Attend Investor Conferences in January
Jan 06, 2016 13:00 pm UTC| Business
VANCOUVER, Wash., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Papa Murphy’s Holdings, Inc. (Nasdaq:FRSH) today announced the Company will present at two upcoming investor conferences. On Tuesday, January 12, 2016, the Company...
AMAG Pharmaceuticals Announces $60 Million Share Repurchase Program
Jan 06, 2016 13:00 pm UTC| Business
WALTHAM, Mass., Jan. 06, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that its Board of Directors has approved a share repurchase program under which AMAG may purchase up to $60...
Jan 06, 2016 13:00 pm UTC| Business
New Haven, CT, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat bacterial infections, announced the initiation of an international Phase 3...